Archives
-
Azithromycin and Roxithromycin as Senolytics
2026-08-31
Ozsvari and colleagues used a DNA-damage-induced human fibroblast model to screen approved antibiotics for selective activity against senescent cells. The study identified azithromycin and roxithromycin as senolytic candidates, while closely related erythromycin lacked comparable activity, highlighting the value of structure-sensitive drug repurposing and orthogonal senescent cell detection.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-31
HRP Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1223, provides enzyme-linked detection of rabbit IgG for Western blotting, ELISA, IHC, and immunocytochemistry. It is intended for research workflows only, not diagnostic or medical use, and should be validated with the selected primary antibody, sample matrix, substrate, and imaging system.
-
WY-14643: Practical PPARα Assay Workflows
2026-08-30
WY-14643 (Pirinixic Acid) provides a practical pathway-activation tool for studying lipid metabolism, endothelial inflammation, and insulin sensitivity. This guide connects receptor-focused assays with integrated omics, exposure design, and troubleshooting strategies for more defensible metabolic disorder research.
-
NLRP10 and Epidermal Homeostasis in Atopic Dermatitis
2026-08-29
The reference study establishes NLRP10 as a functional regulator of epidermal homeostasis rather than only an atopic dermatitis susceptibility locus. Using human skin evidence and an air-lift skin-equivalent model, it links NLRP10 to keratinocyte survival through caspase-8 control and to differentiation and barrier formation through p63 stabilization.
-
Biotin-XX Tyramide Reagent for Synaptic Mapping
2026-08-28
Biotin-XX Tyramide Reagent combines HRP-driven signal amplification with membrane-impermeant surface labeling, making it useful for detecting scarce proteins at neuronal membranes and tissue interfaces. This guide translates activity-dependent LGI1 biology into practical IHC, ISH, and proximity-labeling workflows while emphasizing controls, timing, and troubleshooting.
-
Biotin-XX Tyramide Reagent for Spatial Biology
2026-08-28
Biotin-XX Tyramide Reagent converts HRP localization into a highly sensitive, membrane-restricted spatial readout for IHC and ISH. This article explains how biotin-LC-LC-tyramide can clarify cell-surface signaling and migration biology without confusing amplification with mechanistic proof.
-
FLNa–NF-κB Control of Hepatitis E Virus Replication
2026-08-27
The reference study identifies filamin A (FLNa) as a host cytoskeletal factor that connects HEV infection with NF-κB signaling, apoptosis, and inflammatory responses. Its evidence suggests that HEV-driven suppression of FLNa blocks IκB degradation and NF-κB nuclear translocation, creating conditions that favor viral replication and virion release.
-
Bleomycin Sulfate: DNA Damage to Fibrosis
2026-08-27
Bleomycin Sulfate, also known as Blenoxane, is more than a cytotoxic reagent: it is a controllable gateway from DNA strand breaks to inflammatory and fibrotic signaling. This thought-leadership guide connects mechanistic assays, pulmonary fibrosis research, and macrophage-targeted STING editing to improve translational study design.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-26
Build sensitive, reproducible fluorescence workflows for mapping ASB3–MAVS signaling across immunofluorescence, western blotting, immunohistochemistry, and flow cytometry. This guide combines mechanism-led assay design with practical dilution, storage, imaging, and troubleshooting recommendations for a Cy5 conjugated secondary antibody.
-
BRD4 Inhibition Primes Erastin-Induced Ferroptosis
2026-08-26
The 2024 Discover Oncology study shows that pharmacological or genetic BRD4 inhibition broadly sensitizes several cell lines to erastin-induced ferroptosis. Its central mechanistic contribution is linking this sensitization to reactive oxygen species accumulation and reduced FSP1 expression, while also revealing cell-specific changes in other ferroptosis regulators.
-
Early Life Adversity, Oxytocin, and Innate Defense
2026-08-25
Tan et al. report that early life adversity caused by postnatal social deprivation disrupts looming-evoked innate defensive behavior in mice through reduced oxytocin signaling in the superior colliculus. The study combines behavioral testing, receptor manipulation, circuit analysis, and intranasal oxytocin rescue to connect early experience with a specific threat-response pathway.
-
Coelenterazine for ROS and Reporter Assays
2026-08-25
Coelenterazine connects luciferase reporter readouts with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide shows how to build compatible reporter, BRET, HTS, oxidative stress, and cancer-associated ROS imaging workflows while controlling solvent, timing, and background.
-
DPPH Assay: From Radical Signal to Decisions
2026-08-24
DPPH enables rapid in vitro antioxidant screening, but its greatest value comes from interpreting radical-scavenging data alongside orthogonal chemistry and bioactivity measurements. This guide explains how to turn a DPPH result into a defensible natural-product or drug-discovery decision.
-
BMS-345541: IKK-1/IKK-2 Workflow Guide
2026-08-24
Use BMS-345541 to connect IKK activity with cytokine production, endothelial behavior, and cancer-cell survival. This practical guide translates NF-κB pathway inhibition into dose-finding, angiogenesis, inflammation, and apoptosis workflows while emphasizing controls and troubleshooting.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-23
This scenario-based guide explains how ECL chemiluminescent detection can resolve low-signal and variable immunoblotting problems that arise alongside cell viability, proliferation, and cytotoxicity assays. It evaluates the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, using practical criteria including sensitivity, workflow flexibility, membrane compatibility, and cost-efficiency.